ISSUED ON BEHALF OF REED ELSEVIER PLC AND REED ELSEVIER NV
Reed Elsevier announces that it today received notification of the following transactions in the securities of Reed Elsevier by Erik Engstrom, Director and Ian Fraser, PDMR:
(a) Reed Elsevier Group plc Bonus Investment Plan 2010 ("BIP")
Vesting of matching shares
In connection with the vesting on 25 April 2013 of the share awards granted in May 2010 under the BIP, the table below shows the total numbers of shares which vested and the numbers of shares actually released to Erik Engstrom and Ian Fraser after taking account of shares withheld to meet personal tax and social security obligations.
|
No. of Reed Elsevier PLC ordinary shares/ADRs* vested |
No. of Reed Elsevier NV ordinary shares/ADRs* vested |
No. of Reed Elsevier PLC ordinary shares/ADRs* released |
No. of Reed Elsevier NV ordinary shares/ADRs* released |
Director |
|
|
|
|
Erik Engstrom |
|
62,819* |
|
33,294* |
|
|
|
|
|
PDMR |
|
|
|
|
Ian Fraser |
38,163 |
|
20,226 |
|
|
|
24,939 |
|
13,217 |
*Denotes vesting/release of ADRs. Each Reed Elsevier NV ADR represents 2 Reed Elsevier NV ordinary shares.
The closing market price of each security on the date of vesting was £7.76 per Reed Elsevier PLC ordinary share, €13.15 per Reed Elsevier NV ordinary share and $34.06 per Reed Elsevier NV ADR.
(b) Reed Elsevier Group plc Long Term Incentive Plan ("LTIP")
Vesting of performance shares
In connection with the vesting on 25 April 2013 of the share awards granted in May 2010 under the LTIP, the table below shows the total numbers of shares which vested and the numbers of shares actually released to Ian Fraser after taking account of shares withheld to meet personal tax and social security obligations.
|
No. of Reed Elsevier PLC ordinary shares vested |
No. of Reed Elsevier NV ordinary shares vested |
No. of Reed Elsevier PLC ordinary shares released |
No. of Reed Elsevier NV ordinary shares released |
PDMR |
|
|
|
|
Ian Fraser |
44,795 |
|
23,741 |
|
|
|
29,416 |
|
15,590 |
The closing market price of each security on the date of vesting was £7.76 per Reed Elsevier PLC ordinary share and €13.15 per Reed Elsevier NV ordinary share.
(c) Reed Elsevier Group plc Growth Plan 2010 ("REGP")
Vesting of performance shares
In connection with the vesting on 25 April 2013 of the share awards granted in May 2010 under the REGP, the table below shows the total numbers of shares which vested and the numbers of shares actually released to Erik Engstrom after taking account of shares withheld to meet personal tax and social security obligations.
|
No. of Reed Elsevier PLC ordinary shares vested |
No. of Reed Elsevier NV ordinary shares vested |
No. of Reed Elsevier PLC ordinary shares released |
No. of Reed Elsevier NV ordinary shares released |
Director |
|
|
|
|
Erik Engstrom |
214,855 |
141,093 |
113,873 |
74,779 |
The closing market price of each security on the date of vesting was £7.76 per Reed Elsevier PLC ordinary share and €13.15 per Reed Elsevier NV ordinary share.
In addition, an equal number of performance shares became deferred performance shares, subject to release in 2015 (see notification below regarding the grant of matching shares).
Grant of matching shares
In accordance with the REGP rules, the following grant of matching shares was made to Erik Engstrom on 25 April 2013.
|
No. of Reed Elsevier PLC ordinary shares |
No. of Reed Elsevier PLC ADRs |
No. of Reed Elsevier NV ordinary shares |
No. of Reed Elsevier NV ADRs |
Director |
|
|
|
|
Erik Engstrom |
304,891 |
4,251 |
400,980 |
24,757 |
The number of matching shares awarded is determined in accordance with the REGP rules and is equal to the deferred performance shares (see notification immediately above) plus Mr Engstrom's 300% of base salary personal shareholding he invested to participate in the REGP.
The number of matching shares which may actually vest will be determined by three separate performance measures - Relative Total Shareholder Return measures (TSR measure), a Return on Invested Capital measure (ROIC) and an adjusted Earnings Per Share measure (EPS measure) measured over financial years 2013 and 2014 - and is subject to the overall plan cap.
(d) Reed Elsevier Group plc Long Term Incentive Share Option Scheme ("LTIS") and Reed Elsevier Group plc Share Option Scheme ("ESOS"): Exercise of Options
The following options to acquire Reed Elsevier shares were exercised by Erik Engstrom and Ian Fraser on 29 April 2013.
|
Date of grant |
Plan name |
No. of Reed Elsevier PLC ordinary shares |
No. of Reed Elsevier NV ordinary shares |
Option price per share |
Director |
|
|
|
|
|
Erik Engstrom |
23 August 2004 |
LTIS |
325,163 |
|
£4.78 |
|
23 August 2004 |
LTIS |
|
224,766 |
€10.30 |
|
23 August 2004 |
ESOS |
63,460 |
|
£4.78 |
|
23 August 2004 |
ESOS |
|
43,866 |
€10.30 |
|
|
|
|
|
|
PDMR |
|
|
|
|
|
Ian Fraser |
18 November 2005 |
LTIS |
|
61,350 |
€11.35 |
|
13 March 2006 |
ESOS |
52,747 |
|
£5.305 |
|
13 March 2006 |
ESOS |
|
39,240 |
€11.47 |
|
19 February 2009 |
ESOS |
54,305 |
|
£5.42 |
|
19 February 2009 |
ESOS |
|
35,261 |
€9.415 |
(e) Sale of shares
On 29 April 2013, Erik Engstrom and Ian Fraser sold the following shares set out below.
|
No. of Reed Elsevier PLC ordinary shares/ADRs* sold |
Price per Reed Elsevier PLC ordinary shares/ADRs** |
No. of Reed Elsevier NV ordinary shares/ADRs* sold |
Price per Reed Elsevier NV ordinary shares/ADRs** |
Director |
|
|
|
|
Erik Engstrom |
498,996 |
£7.531127 |
341,211 |
€12.8101 |
|
|
|
33,294* |
$33.5316** |
|
|
|
|
|
PDMR |
|
|
|
|
Ian Fraser |
151,019 |
£7.531127 |
164,658 |
€12.8241 |
|
|
|
|
|
|
|
|
|
|
*Denotes sale of ADRs. Each Reed Elsevier NV ADR represents 2 Reed Elsevier NV ordinary shares.
** Denotes price per ADR
Following these transactions, the current interests of Erik Engstrom in the share capital of Reed Elsevier PLC and Reed Elsevier NV are:
Reed Elsevier PLC 110,540 ordinary shares
Reed Elsevier NV 511,756 ordinary shares
Note: The Reed Elsevier 2012 Directors' Remuneration Report is available to view or download at Reed Elsevier's website www.reedelsevier.com.
- ENDS -
Enquiries
Paul Abrahams (Media)
+44 20 7166 5724
Colin Tennant (Investors)
+44 20 7166 5751